Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Webster K Cavenee

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Cancer Biology & Therapy|May 17, 2003
Preparing for serendipityWebster K Cavenee
Genes, Chromosomes & Cancer|October 21, 2003
The recessive nature of dominanceWebster K Cavenee
Carcinogenesis|May 23, 2002
Genetics and new approaches to cancer therapyWebster K Cavenee
Nature Medicine|November 2, 2002
Muscling in on rhabdomyosarcomaWebster K Cavenee
Cancer Prevention Research (Philadelphia, Pa.)|August 23, 2012
Genetic driver events in premalignancy: LOH validated for marking the risk of oral cancerWebster K Cavenee
Neuro-Oncology|February 25, 2009
Stem cells for treating glioblastoma: how close to reality?C David James, Webster K Cavenee
Journal of Neurosurgery|March 21, 2007
Synergistic cytotoxicity through the activation of multiple apoptosis pathways in human glioma cells induced by combined treatment with ionizing radiation and tumor necrosis factor-related apoptosis-inducing ligandMotoo Nagane, Webster K Cavenee, Yoshiaki Shiokawa
NPJ Precision Oncology|June 7, 2018
Precision cancer therapy is impacted by oncogene-dependent epigenome remodelingFeng Liu, Paul S Mischel, Webster K Cavenee
Methods in Molecular Biology (Clifton, N.J.)|April 16, 2002
Restriction landmark genome scanningJoseph F Costello, Christoph Plass, Webster K Cavenee
Brain Tumor Pathology|June 14, 2016
Cancer metabolism as a central driving force of glioma pathogenesisKenta Masui, Webster K Cavenee, Paul S Mischel
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Cancer Biology & Therapy|May 17, 2003
Preparing for serendipityWebster K Cavenee
Genes, Chromosomes & Cancer|October 21, 2003
The recessive nature of dominanceWebster K Cavenee
Carcinogenesis|May 23, 2002
Genetics and new approaches to cancer therapyWebster K Cavenee
Nature Medicine|November 2, 2002
Muscling in on rhabdomyosarcomaWebster K Cavenee
Cancer Prevention Research (Philadelphia, Pa.)|August 23, 2012
Genetic driver events in premalignancy: LOH validated for marking the risk of oral cancerWebster K Cavenee
Neuro-Oncology|February 25, 2009
Stem cells for treating glioblastoma: how close to reality?C David James, Webster K Cavenee
Journal of Neurosurgery|March 21, 2007
Synergistic cytotoxicity through the activation of multiple apoptosis pathways in human glioma cells induced by combined treatment with ionizing radiation and tumor necrosis factor-related apoptosis-inducing ligandMotoo Nagane, Webster K Cavenee, Yoshiaki Shiokawa
NPJ Precision Oncology|June 7, 2018
Precision cancer therapy is impacted by oncogene-dependent epigenome remodelingFeng Liu, Paul S Mischel, Webster K Cavenee
Methods in Molecular Biology (Clifton, N.J.)|April 16, 2002
Restriction landmark genome scanningJoseph F Costello, Christoph Plass, Webster K Cavenee
Brain Tumor Pathology|June 14, 2016
Cancer metabolism as a central driving force of glioma pathogenesisKenta Masui, Webster K Cavenee, Paul S Mischel
Pageof 15